Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
Authors
Keywords
-
Journal
SEMINARS IN CANCER BIOLOGY
Volume 96, Issue -, Pages 64-81
Publisher
Elsevier BV
Online
2023-10-10
DOI
10.1016/j.semcancer.2023.10.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR–dCas12a-mediated genetic circuit cascades for multiplexed pathway optimization
- (2023) Yaokang Wu et al. Nature Chemical Biology
- A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment
- (2023) Xianguang Yang et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond – A lipids focus
- (2023) Shikha Rani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The era of Cas12 and Cas13 CRISPR-based disease diagnosis
- (2022) Mandeep Singh et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells
- (2022) Zahra Noroozi et al. Scientific Reports
- Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
- (2022) Shuying Feng et al. Frontiers in Cell and Developmental Biology
- Extracellular Vesicles and Their Emerging Roles as Cellular Messengers in Endocrinology: An Endocrine Society Scientific Statement
- (2022) Carlos Salomon et al. ENDOCRINE REVIEWS
- Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9
- (2022) Lifang Xie et al. FEBS Journal
- Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020
- (2022) Citadel J. Cabasag et al. INTERNATIONAL JOURNAL OF CANCER
- Structural biology of CRISPR–Cas immunity and genome editing enzymes
- (2022) Joy Y. Wang et al. NATURE REVIEWS MICROBIOLOGY
- Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants
- (2022) Jon Arizti-Sanz et al. Nature Biomedical Engineering
- Encapsulating Cas9 into extracellular vesicles by protein myristoylation
- (2022) Joseph Andrew Whitley et al. Journal of Extracellular Vesicles
- A target expression threshold dictates invader defense and prevents autoimmunity by CRISPR-Cas13
- (2022) Elena Vialetto et al. Cell Host & Microbe
- CRISPR‐Cas‐based detection for food safety problems: Current status, challenges, and opportunities
- (2022) Yaru Li et al. COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY
- Progress of delivery methods for CRISPR-Cas9
- (2022) Wu Yang et al. Expert Opinion on Drug Delivery
- CRISPR-RNAa: targeted activation of translation using dCas13 fusions to translation initiation factors
- (2022) Peter B Otoupal et al. NUCLEIC ACIDS RESEARCH
- The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy
- (2022) Kewen Qian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
- (2022) Qiurong Yang et al. Advanced Science
- Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
- (2022) Astrid Murumägi et al. BRITISH JOURNAL OF CANCER
- A CRISPR/Cas13a-powered catalytic electrochemical biosensor for successive and highly sensitive RNA diagnostics
- (2021) Yan Sheng et al. BIOSENSORS & BIOELECTRONICS
- Overcoming PARPi resistance: preclinical and clinical evidence in ovarian cancer
- (2021) M. Chiappa et al. DRUG RESISTANCE UPDATES
- A Versatile Platform for Generating Engineered Extracellular Vesicles with Defined Therapeutic Properties
- (2021) Kevin Dooley et al. MOLECULAR THERAPY
- CRISPR technologies for precise epigenome editing
- (2021) Muneaki Nakamura et al. NATURE CELL BIOLOGY
- Extracellular vesicles versus synthetic nanoparticles for drug delivery
- (2021) Kenneth W. Witwer et al. Nature Reviews Materials
- A Simple and Quick Method for Loading Proteins in Extracellular Vesicles
- (2021) Sara Busatto et al. Pharmaceuticals
- Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
- (2021) Lili Cheng et al. BIOMATERIALS
- Synthetic Lethality in Ovarian Cancer
- (2021) Akshaya Chandrasekaran et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
- (2021) America Campos et al. Cancers
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The promise and challenge of therapeutic genome editing
- (2020) Jennifer A. Doudna NATURE
- A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy
- (2020) Jing Fan et al. ACS Synthetic Biology
- Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
- (2020) Abishek Wadhwa et al. Pharmaceutics
- Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
- (2020) Peter Gee et al. Nature Communications
- CRISPRi-dCas12a: A dCas12a-Mediated CRISPR Interference for Repression of Multiple Genes and Metabolic Engineering in Cyanobacteria
- (2020) Sun Young Choi et al. ACS Synthetic Biology
- CRISPR/Cas13a Powered Portable Electrochemiluminescence Chip for Ultrasensitive and Specific MiRNA Detection
- (2020) Ting Zhou et al. Advanced Science
- Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib
- (2020) Cong He et al. EXPERIMENTAL CELL RESEARCH
- Gene Editing by Extracellular Vesicles
- (2020) Dmitry Kostyushev et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular vesicles engineered with valency-controlled DNA nanostructures deliver CRISPR/Cas9 system for gene therapy
- (2020) Jialang Zhuang et al. NUCLEIC ACIDS RESEARCH
- Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
- (2020) Anne M. Macpherson et al. Journal of Clinical Medicine
- Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
- (2020) Maturada Patchsung et al. Nature Biomedical Engineering
- Current Clinical Applications of In Vivo Gene Therapy with AAVs
- (2020) Jerry R. Mendell et al. MOLECULAR THERAPY
- A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy
- (2020) Jinliang Gao et al. Molecular Therapy-Oncolytics
- Synthetic lethality guiding selection of drug combinations in ovarian cancer
- (2019) Andreas Heinzel et al. PLoS One
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Engineered CRISPR–Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing
- (2019) Benjamin P. Kleinstiver et al. NATURE BIOTECHNOLOGY
- Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression
- (2019) Tamaki Yahata et al. CANCER SCIENCE
- The next generation of CRISPR–Cas technologies and applications
- (2019) Adrian Pickar-Oliver et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
- (2019) Shayesteh R. Ferdosi et al. Nature Communications
- Transposon-encoded CRISPR–Cas systems direct RNA-guided DNA integration
- (2019) Sanne E. Klompe et al. NATURE
- Extracellular vesicles: a new communication paradigm?
- (2019) Graça Raposo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- RNA-guided DNA insertion with CRISPR-associated transposases
- (2019) Jonathan Strecker et al. SCIENCE
- Olaparib in the treatment of ovarian cancer
- (2019) Christina R. Washington et al. Future Oncology
- Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
- (2019) Zhanzhan Zhang et al. ADVANCED MATERIALS
- Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis
- (2019) Wei Zhang et al. BMC CANCER
- Immunogenicity of Cas9 Protein
- (2019) Aditi Mehta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
- (2019) Xiaojing Shi et al. MOLECULAR THERAPY
- CRISPR/Cas13a Signal Amplification Linked Immunosorbent Assay for Femtomolar Protein Detection
- (2019) Qian Chen et al. ANALYTICAL CHEMISTRY
- The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model
- (2019) Weisong Duan et al. GENE THERAPY
- Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
- (2019) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
- (2019) Daelyn Y. Richards et al. Molecular Therapy-Methods & Clinical Development
- Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy
- (2018) Tian Tian et al. BIOMATERIALS
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors
- (2018) Silvana Konermann et al. CELL
- dCas9: A Versatile Tool for Epigenome Editing
- (2018) Daan J.W. Brocken et al. CURRENT ISSUES IN MOLECULAR BIOLOGY
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
- (2018) Yoshizumi Ishino et al. JOURNAL OF BACTERIOLOGY
- A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer
- (2018) Yan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
- (2018) Haiying Zhang et al. NATURE CELL BIOLOGY
- Field-deployable viral diagnostics using CRISPR-Cas13
- (2018) Cameron Myhrvold et al. SCIENCE
- Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6
- (2018) Jonathan S. Gootenberg et al. SCIENCE
- CRISPR/Cas13 as a Tool for RNA Interference
- (2018) Zahir Ali et al. TRENDS IN PLANT SCIENCE
- Efficient RNA drug delivery using red blood cell extracellular vesicles
- (2018) Waqas Muhammad Usman et al. Nature Communications
- VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
- (2018) Claudia Montagna et al. Molecular Therapy-Nucleic Acids
- Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
- (2018) Yao Lin et al. Advanced Science
- Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris
- (2018) Sarah Caruso et al. Frontiers in Immunology
- The Origin and Functions of Exosomes in Cancer
- (2018) Chitra Rajagopal et al. Frontiers in Oncology
- Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
- (2018) D.C. Luther et al. Expert Opinion on Drug Delivery
- Exosomal microRNAs as tumor markers in epithelial ovarian cancer
- (2018) Chi Pan et al. Molecular Oncology
- A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
- (2018) Christopher A. Vakulskas et al. NATURE MEDICINE
- Circulating Extracellular Vesicles in Human Disease
- (2018) Ravi Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR-Cas guides the future of genetic engineering
- (2018) Gavin J. Knott et al. SCIENCE
- mRNA as novel technology for passive immunotherapy
- (2018) Thomas Schlake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Immunotherapies based on PD-1/PD-L1 pathway inhibitors in ovarian cancer treatment
- (2018) A. Pawłowska et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
- (2018) Lee A. Campbell et al. MOLECULAR THERAPY
- In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9
- (2018) Zhelong Li et al. NANO LETTERS
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
- (2018) Philippe E. Mangeot et al. Nature Communications
- Delivery of an Artificial Transcription Regulator dCas9-VPR by Extracellular Vesicles for Therapeutic Gene Activation
- (2018) Duško Lainšček et al. ACS Synthetic Biology
- Viral vector-based delivery of CRISPR/Cas9 and donor DNA for homology directed repair in an in vitro model for canine hemophilia B
- (2018) Jian Gao et al. Molecular Therapy-Nucleic Acids
- APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner
- (2017) Yuyin Yi et al. GYNECOLOGIC ONCOLOGY
- Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
- (2017) Mauro Cataldi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
- (2017) Seung Min Kim et al. JOURNAL OF CONTROLLED RELEASE
- Genome editing via delivery of Cas9 ribonucleoprotein
- (2017) Mark A. DeWitt et al. METHODS
- Engineered Exosomes as Vehicles for Biologically Active Proteins
- (2017) Ulrich Sterzenbach et al. MOLECULAR THERAPY
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
- (2017) Fengmei Pi et al. Nature Nanotechnology
- Diversity and evolution of class 2 CRISPR–Cas systems
- (2017) Sergey Shmakov et al. NATURE REVIEWS MICROBIOLOGY
- CRISPR-Cas: Adapting to change
- (2017) Simon A. Jackson et al. SCIENCE
- Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
- (2017) Guannan Zhao et al. Oncotarget
- Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells
- (2017) Wenying Huo et al. Journal of Cancer
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- Antiangiogenic Therapies in Epithelial Ovarian Cancer
- (2017) Deanna G. K. Teoh et al. Cancer Control
- PARP inhibitors in ovarian cancer
- (2016) J. A. Ledermann ANNALS OF ONCOLOGY
- Extracellular vesicles as novel carriers for therapeutic molecules
- (2016) Nambin Yim et al. BMB Reports
- microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP
- (2016) Xiaodi Li et al. BRITISH JOURNAL OF CANCER
- The immunoglobulin-like superfamily member IGSF3 is a developmentally regulated protein that controls neuronal morphogenesis
- (2016) Alessia Usardi et al. Developmental Neurobiology
- Immune checkpoint inhibition in ovarian cancer
- (2016) Junzo Hamanishi et al. INTERNATIONAL IMMUNOLOGY
- Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes
- (2016) Sean Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The biology and function of exosomes in cancer
- (2016) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity
- (2016) Josh Tycko et al. MOLECULAR CELL
- Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
- (2016) Xiaodan Meng et al. Oncotarget
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- A role for peptides in overcoming endosomal entrapment in siRNA delivery — A focus on melittin
- (2015) Kirk K. Hou et al. BIOTECHNOLOGY ADVANCES
- The CRISPR/Cas9 system for plant genome editing and beyond
- (2015) Luisa Bortesi et al. BIOTECHNOLOGY ADVANCES
- The structural biology of CRISPR-Cas systems
- (2015) Fuguo Jiang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- The Effect of Glucose on the Release and Bioactivity of Exosomes From First Trimester Trophoblast Cells
- (2015) Gregory E. Rice et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
- (2015) Michael Boettcher et al. MOLECULAR CELL
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- Highly efficient Cas9-mediated transcriptional programming
- (2015) Alejandro Chavez et al. NATURE METHODS
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes
- (2015) Ikuhiko Nakase et al. Scientific Reports
- Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter
- (2014) Charles P. Lai et al. ACS Nano
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Guide RNA Functional Modules Direct Cas9 Activity and Orthogonality
- (2014) Alexandra E. Briner et al. MOLECULAR CELL
- Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
- (2014) Dirk Heckl et al. NATURE BIOTECHNOLOGY
- Emerging role of extracellular vesicles in inflammatory diseases
- (2014) Edit I. Buzas et al. Nature Reviews Rheumatology
- Cas9 Targeting and the CRISPR Revolution
- (2014) R. Barrangou SCIENCE
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- PARP inhibition and synthetic lethality in ovarian cancer
- (2014) Ramez N Eskander et al. Expert Review of Clinical Pharmacology
- AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
- (2014) R. Jude Samulski et al. Annual Review of Virology
- CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
- (2013) Luke A. Gilbert et al. CELL
- Immune Sensing of DNA
- (2013) Søren R. Paludan et al. IMMUNITY
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays
- (2013) Brian M. Nolen et al. Molecular Diagnosis & Therapy
- Cas9 as a versatile tool for engineering biology
- (2013) Prashant Mali et al. NATURE METHODS
- CRISPR RNA–guided activation of endogenous human genes
- (2013) Morgan L Maeder et al. NATURE METHODS
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- Extracellular vesicles: biology and emerging therapeutic opportunities
- (2013) Samir EL Andaloussi et al. NATURE REVIEWS DRUG DISCOVERY
- Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and Vasculogenesis
- (2013) Carlos Salomon et al. PLoS One
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
- (2012) Ting Gui et al. Cancer Epidemiology
- Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
- (2012) Shin-ichiro Ohno et al. MOLECULAR THERAPY
- Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
- (2012) Joe Bondy-Denomy et al. NATURE
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts
- (2011) Jung Ah Cho et al. GYNECOLOGIC ONCOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- Evolution and classification of the CRISPR–Cas systems
- (2011) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Exosomes: Extracellular organelles important in intercellular communication
- (2010) Suresh Mathivanan et al. Journal of Proteomics
- Diversity of CRISPR loci in Escherichia coli
- (2010) MICROBIOLOGY-SGM
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
- (2010) Dongmei Sun et al. MOLECULAR THERAPY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Current Review of Targeted Therapeutics for Ovarian Cancer
- (2010) Susana M. Campos et al. Journal of Oncology
- Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
- (2009) Jianghong Li et al. BMC CANCER
- First-line treatment of advanced ovarian cancer: current research and perspectives
- (2009) Claudia Marchetti et al. Expert Review of Anticancer Therapy
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started